Cargando…

Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit?

Detalles Bibliográficos
Autores principales:	Garvey, Lene H., Nasser, Shuaib
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd on behalf of British Journal of Anaesthesia. 2021
Materias:	COVID-19 Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834677/ https://www.ncbi.nlm.nih.gov/pubmed/33386124 http://dx.doi.org/10.1016/j.bja.2020.12.020

Ejemplares similares

Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines
por: Risma, Kimberly A., et al.
Publicado: (2021)

Multivessel coronary thrombosis in a COVID-19 patient: Lungs are not always a culprit
por: Kuzemczak, Michał, et al.
Publicado: (2021)

mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis
por: Rama, Tiago Azenha, et al.
Publicado: (2021)

M044 POLYETHYLENE GLYCOL ALLERGY TESTING AN ADOLESCENT WITH ANAPHYLAXIS TO PEG-ASPARAGINASE BEFORE ADMINISTERING PFIZER-BIONTECH COVID-19 VACCINE
por: Breidenbaugh, M.
Publicado: (2021)

May polyethylene glycol be the cause of anaphylaxis to mRNA COVID-19 vaccines?()
por: Giavina-Bianchi, Pedro, et al.
Publicado: (2021)

COVID-19 vaccine hesitancy among first-generation immigrants living in Sweden
por: Svallfors, Signe, et al.
Publicado: (2023)

Authors’ Reply: Vaccination, payment, and COVID-19
por: Dotlic, Jelena, et al.
Publicado: (2021)

Polyethylene glycol as a cause of anaphylaxis
por: Wylon, Katharina, et al.
Publicado: (2016)

Letter to the Editor: Financial incentives for COVID-19 vaccination
por: Kim, Hyuncheol Bryant
Publicado: (2021)

New COVID-19 Transmission after the First Vaccine Dose at Skilled Nursing Facilities in Nebraska
por: Kamal-Ahmed, Ishrat, et al.
Publicado: (2021)

COVID-19 Vaccination of HCWs in the First Phase of a Large-Scale Mass Vaccination Program within a Healthcare System
por: Korwek, Kimberly, et al.
Publicado: (2021)

Experience with polyethylene glycol allergy‐guided risk management for COVID‐19 vaccine anaphylaxis
por: Brockow, Knut, et al.
Publicado: (2021)

Impact of COVID-19 on neurological manifestations: an overview of stroke presentation in pandemic
por: Fatima, Nida, et al.
Publicado: (2020)

We Need to Inform COVID-19 Vaccinating Clinics Concerning Polyethylene Glycol Allergy
por: Gelfman, Daniel M.
Publicado: (2021)

Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG
por: Kozma, Gergely Tibor, et al.
Publicado: (2023)

COVID-19-Vaccine-Pfizer-BioNTech: Anaphylaxis to excipient polyethylene glycol: case report
Publicado: (2021)

Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases
por: Bouattour, Nadia, et al.
Publicado: (2021)

Against COVID‐19 vaccination of healthy children
por: Kraaijeveld, Steven R., et al.
Publicado: (2022)

Methylprednisolone/peg-3350/sodium-chloride/sodium-bicarbonate/potassium-chloride/phenoxymethylpenicillin: Anaphylaxis to the polyethylene glycol (PEG) excipients : 2 case reports
Publicado: (2022)

The application of polyethylene glycol (PEG) to electron microscopy
Publicado: (1980)

Dengue–COVID-19 coinfection: the first reported case in the Philippines
por: Saipen, Angyap, et al.
Publicado: (2021)

Queue questions: Ethics of COVID‐19 vaccine prioritization
por: Giubilini, Alberto, et al.
Publicado: (2021)

Spectrum of neurological complications following COVID-19 vaccination
por: Garg, Ravindra Kumar, et al.
Publicado: (2021)

Functional neurological disorder after COVID-19 vaccination
por: Ercoli, Tommaso, et al.
Publicado: (2021)

Heart inflammation risk after COVID-19 vaccine
por: Szarpak, Lukasz, et al.
Publicado: (2021)

Bilateral facial palsy after COVID-19 vaccination
por: Andreozzi, Valentina, et al.
Publicado: (2022)

Quantifying the effect of personal protective equipment on speech understanding
por: Malin, Alexander, et al.
Publicado: (2021)

Letter to the Editor: Enhancing COVID-19 vaccination coverage using financial incentives: arguments to help health providers counterbalance erroneous claims
por: Choi, Yong-jun
Publicado: (2021)

Respiratory dysfunction as first presentation of myasthenia gravis misdiagnosed as COVID-19
por: Scopelliti, Giuseppe, et al.
Publicado: (2020)

Impact of COVID-19 on nutritional status during the first wave of the pandemic
por: Ramos, Analía, et al.
Publicado: (2022)

Cost of Personal Protective Equipment During the First Wave of COVID-19
por: Mena Lora, Alfredo, et al.
Publicado: (2021)

Parental concerns about COVID-19 vaccine safety and hesitancy in Korea: implications for vaccine communication
por: Cho, Hye-Kyung, et al.
Publicado: (2022)

On BCG Vaccine Protection from COVID-19: A Review
por: Bagheri, Narges, et al.
Publicado: (2021)

Miller Fisher syndrome following Pfizer COVID-19 vaccine
por: Abičić, Ana, et al.
Publicado: (2021)

The COVID‐19 vaccine intentions of Australian disability support workers
por: Kavanagh, Anne, et al.
Publicado: (2022)

Meralgia paresthetica mimic after Moderna COVID‑19 vaccine
por: Tatum, Peter
Publicado: (2022)

assessment of Vaccine Interest in Unvaccinated COVID-19–positive inpatients
por: Stancill, Lisa, et al.
Publicado: (2022)

First manifestation of AQP4-IgG-positive neuromyelitis optica spectrum disorder following the COVID-19 mRNA vaccine BNT162b2
por: Umezawa, Shu, et al.
Publicado: (2022)

Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine
por: Saito, Kazuyuki, et al.
Publicado: (2021)

Primary COVID-19 vaccine cycle and booster doses efficacy: analysis of Italian nationwide vaccination campaign
por: Mattiuzzi, Camilla, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2e4q7p3obousqfp2vsfb0saj9q